- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Tonghua Dongbao Pharmaceutical Co Ltd (600867)
Tonghua Dongbao Pharmaceutical Co Ltd stock price live, this page displays SS 600867 stock exchange data. View the 600867 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Tonghua Dongbao Pharmaceutical Co Ltd real time stock price chart below.
What Is the Tonghua Dongbao Pharmaceutical Co Ltd Stock Price Today?
The Tonghua Dongbao Pharmaceutical Co Ltd stock price today is 8.71.
What Is the Stock Symbol for Tonghua Dongbao Pharmaceutical Co Ltd?
The stock symbol for Tonghua Dongbao Pharmaceutical Co Ltd is ""600867.""
What Stock Exchange Does Tonghua Dongbao Pharmaceutical Co Ltd Trade On?
Tonghua Dongbao Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is Tonghua Dongbao Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Tonghua Dongbao Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600867 quote. (ISIN: CNE000000H87)
What Is the Tonghua Dongbao Pharmaceutical Co Ltd Stock Price Today?
The Tonghua Dongbao Pharmaceutical Co Ltd stock price today is 8.71.
What Is the Stock Symbol for Tonghua Dongbao Pharmaceutical Co Ltd?
The stock symbol for Tonghua Dongbao Pharmaceutical Co Ltd is ""600867.""
What Stock Exchange Does Tonghua Dongbao Pharmaceutical Co Ltd Trade On?
Tonghua Dongbao Pharmaceutical Co Ltd is listed and trades on the Shanghai stock exchange.
Is Tonghua Dongbao Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Tonghua Dongbao Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600867 quote. (ISIN: CNE000000H87)
Shanghai
Currency in CNY
8.71
+0.10(+1.16%)
Closed·
Fair Value
An estimate of a Tonghua Dongbao Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.66
9.03
52 wk Range
7.00
9.64
600867 Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected today
1/3
Fair Value
An estimate of a Tonghua Dongbao Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.669.03
52 wk Range
7.009.64
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.90%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.90%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600867 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Tonghua Dongbao Pharm's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
9.53
Upside
+9.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Tonghua Dongbao Pharmaceutical Co Ltd Company Profile
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. It offers human insulin API and injections; insulin glargine API and injections; insulin aspart API and injections; liraglutide injections; zhennaoning capsules; and diabetes-related medical devices. The company also provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system. In addition, it offers chemical drugs, such as repaglinide and empagliflozin tablets. Further, the company offers building materials, including plastic steel windows and profiles; and engages in the real estate industry. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.
Compare 600867 to Peers and Sector
Metrics to compare | 600867 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600867PeersSector | |
|---|---|---|---|---|
P/E Ratio | −114.8x | 32.6x | −0.6x | |
PEG Ratio | 1.02 | −0.43 | 0.00 | |
Price/Book | 2.6x | 3.1x | 2.6x | |
Price / LTM Sales | 8.2x | 4.9x | 3.3x | |
Upside (Analyst Target) | 11.9% | 18.9% | 39.0% | |
Fair Value Upside | Unlock | −6.7% | 4.9% | Unlock |
Analyst Ratings
4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.53
(+9.46% Upside)
Earnings
Latest Release
Apr 29, 2025
EPS / Forecast
0.06 / 0.06
Revenue / Forecast
651.50M / 649.06M
FAQ
What Stock Exchange Does Tonghua Dongbao Pharm Trade On?
Tonghua Dongbao Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.
What Is the Stock Symbol for Tonghua Dongbao Pharm?
The stock symbol for Tonghua Dongbao Pharm is "600867."
What Is the Tonghua Dongbao Pharm Market Cap?
As of today, Tonghua Dongbao Pharm market cap is 16.99B.
What Is Tonghua Dongbao Pharm's Earnings Per Share (TTM)?
The Tonghua Dongbao Pharm EPS (TTM) is -0.07.
When Is the Next Tonghua Dongbao Pharm Earnings Date?
Tonghua Dongbao Pharm will release its next earnings report on 25 Aug 2025.
From a Technical Analysis Perspective, Is 600867 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Tonghua Dongbao Pharm Stock Split?
Tonghua Dongbao Pharm has split 12 times.
How Many Employees Does Tonghua Dongbao Pharm Have?
Tonghua Dongbao Pharm has 3410 employees.
What is the current trading status of Tonghua Dongbao Pharm (600867)?
As of 26 Aug 2025, Tonghua Dongbao Pharm (600867) is trading at a price of 8.71, with a previous close of 8.61. The stock has fluctuated within a day range of 8.66 to 9.03, while its 52-week range spans from 7.00 to 9.64.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.